Showing results (251-260 of 636) with videos related to
Sort By:
Pageof 64
Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.Journal of Neurology|August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.Nature Communications|December 2, 2017
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistanceLesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, et al.Iscience|May 25, 2026
Distinct 2-phenylimidazo[1,2-<i>a</i>]pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligandsKatrin Koellisch, Christine Blattner, Stefano Motta, et al.JCO Precision Oncology|May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast CancerJacqueline A Shaw, Karen Page, Evie Wren, et al.Journal of Natural Products|June 20, 2025
Modulation of Estrogen Receptor Activity by the Phytoalexin Tuberosin Produced from Elicited Kudzu (<i>Pueraria lobata</i>)Jorge A Belgodere, Jack R Elliott, Megan C Benz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic RecurrenceRaoul Charles Coombes, Karen Page, Raheleh Salari, et al.Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with <i>SOD1</i>-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.Pageof 64